Berlin
Germany
127
2025-05-29
The entities that hold a legal rights for patent applications filed by inventor Lienau Philip:
Philip Lienau from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
1,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
#2 | 2025-02-27BICYCLIC TRIAZINE DERIVATIVES FOR THE TREATMENT OF CANCER
#3 | 2024-11-07COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATION AND CANCER TREATMENT
#4 | 2024-06-066-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER
#5 | 2024-05-09Covalent PPARG inverse-agonists
#6 | 2024-03-142-Methyl-Quinazolines
#7 | 2023-06-22PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12
#8 | 2023-04-20PYRAZOLOTRIAZINES
#9 | 2023-04-06IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12
#10 | 2023-01-262-METHYL-AZA-QUINAZOLINES
#11 | 2023-01-19Dihydrooxadiazinones
#12 | 2022-12-15Dihydrooxadiazinones
#13 | 2022-09-08NOVEL PTEFB INHIBITING MACROCYCLIC COMPOUNDS
#14 | 2022-09-012-METHYL-AZA-QUINAZOLINES
#15 | 2022-08-25PTEFB inhibiting macrocyclic compounds
#16 | 2022-07-282-METHYL-QUINAZOLINES
#17 | 2021-11-181,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
#18 | 2021-08-05Compounds, compositions and methods for cancer patient stratification and cancer treatment
#19 | 2021-02-184-(3-AMINO-6-FLUORO-1H-INDAZOL-5-YL)-1,2,6-TRIMETHYL-1,4-DIHYDROPYRIDINE-3,5-DIC ARBONITRILE COMPOUNDS FOR TREATING HYPERPROLIFERATIVE DISORDERS
#20 | 2020-12-102-(morpholin-4-yl)-1,7-naphthyridines
#21 | 2020-11-26Dihydrooxadiazinones
#22 | 2020-11-05PTEFb inhibiting macrocyclic compounds
#23 | 2020-08-066-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer
#24 | 2020-04-23PTEFb inhibiting macrocyclic compounds
#25 | 2020-02-27Compounds, compositions and methods for cancer treatment
#26 | 2019-12-05Compounds, compositions and methods for cancer patient stratification and cancer treatment
#27 | 2019-09-19Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
#28 | 2019-05-165-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
#29 | 2019-02-14Heteroarylbenzimidazole compounds
#30 | 2018-10-04Modified macrocyclic compounds
#31 | 2018-09-27Macrocyclic sulfondiimine compounds
#32 | 2018-09-132-(morpholin-4-yl)-1,7-naphthyridines
#33 | 2018-06-14Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors
#34 | 2018-05-31AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES
#35 | 2018-02-151,3,4-THIADIAZOL-2-YL-BENZAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY
#36 | 2018-02-15N-PHENYL-(MORPHOLIN-4-YL OR PIPERAZINYL)ACETAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE WNT SIGNALLING PATHWAYS
#37 | 2018-02-013-CARBAMOYLPHENYL-4-CARBOXAMIDE AND ISOPHTALAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY
#38 | 2018-01-256-HYDROXYBENZOFURANYL- AND 6-ALKOXYBENZOFURANYL-SUBSTITUTED IMIDAZOPYRIDAZINES
#39 | 2018-01-184H-pyrrolo[3,2-C]pyridin-4-one derivatives
#40 | 2017-11-30COMPOUNDS FOR THE TREATMENT OF CANCER
#41 | 2017-09-14Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
#42 | 2017-08-10Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
#43 | 2017-08-034-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
#44 | 2017-08-03Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
#45 | 2017-08-032-(morpholin-4-yl)-1,7-naphthyridines
#46 | 2017-07-205-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
#47 | 2017-07-13BENZOTHIADIAZOLAMINES
#48 | 2017-04-27INHIBITORS OF THE WNT SIGNALLING PATHWAYS
#49 | 2017-04-20SUBSTITUTED TETRAHYDROPYRIDOTHIENOPYRIMIDINES
#50 | 2017-04-20NOVEL COMPOUNDS
#51 | 2017-04-133-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
#52 | 2017-02-02Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
#53 | 2017-02-02Macrocyclic compounds
#54 | 2017-01-26Amido-substituted azole compounds
#55 | 2017-01-19Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
#56 | 2017-01-055-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
#57 | 2016-10-13THIENOPYRIMIDINES AS MKNK1 AND MKNK2 INHIBITORS
#58 | 2016-10-13Substituted triazolopyridines
#59 | 2016-10-062-(morpholin-4-yl)-1,7-naphthyridines
#60 | 2016-10-06SUBSTITUTED-IMIDAZOPYRIDAZINES
#61 | 2016-09-15SUBSTITUTED TRIAZOLOPYRIDINES HAVING ACTIVITY AS MPS-1 INHIBITORS
#62 | 2016-09-15Compounds
#63 | 2016-07-21NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER
#64 | 2016-07-21Prodrug derivatives of substituted triazolopyridines
#65 | 2016-06-09SUBSTITUTED THIENOPYRIMIDINES AND PHARMACEUTICAL USE THEREOF
#66 | 2016-06-09SUBSTITUTED PYRAZOLOPYRIDINES
#67 | 2016-05-19Substituted benzoxazoles
#68 | 2016-04-21TRIAZOLOPYRIDINES AS THROMBIN INHIBITORS FOR THE TREATMENT OF THROMBOEMBOLIC DISEASES
#69 | 2016-04-21SUBSTITUTED BENZOXAZOLES
#70 | 2016-02-25NOVEL COMPOUNDS
#71 | 2016-01-14Substituted thiazolopyrimidines
#72 | 2016-01-07Substituted pyrazolopyrimidinylamino-indazoles
#73 | 2015-12-31Amidoimidazopyridazines as MKNK-1 kinase inhibitors
#74 | 2015-12-24Amino-substituted isothiazoles
#75 | 2015-10-15Aminoimidazopyridazines
#76 | 2015-10-15N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
#77 | 2015-10-154-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
#78 | 2015-10-155-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
#79 | 2015-10-01N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
#80 | 2015-10-015-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
#81 | 2015-09-174-(ORTHO)-FLUOROPHENYL-5-FLUOROPYRIMIDIN-2-YL AMINES CONTAINING A SULFONE GROUP
#82 | 2015-09-10SUBSTITUTED INDAZOL-PYRROLOPYRIMIDINES USEFUL IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
#83 | 2015-08-27Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors
#84 | 2015-08-06SUBSTITUTED INDAZOL-PYRROLOPYRIMIDINES USEFUL IN THE TREATMENT OF HYPERFOLIFERATIVE DISORDERS
#85 | 2015-06-04Substituted benzothienopyrimidines
#86 | 2015-05-14SUBSTITUTED PYRROLOPYRIMIDINES
#87 | 2015-05-14Thienopyrimidines
#88 | 2015-04-02Amino-substituted imidazopyridazines
#89 | 2015-03-26Amino-substituted imidazopyridazines
#90 | 2015-02-05Heterocyclyl aminoimidazopyridazines
#91 | 2015-01-01Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
#92 | 2014-12-11Amino-substituted imidazopyridazines
#93 | 2014-10-234-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
#94 | 2014-10-02Amino-substituted imidazopyridazines
#95 | 2014-09-25AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES AS MKNK1 KINASE INHIBITORS
#96 | 2014-09-04Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
#97 | 2014-08-14Disubstituted 5-fluoro-pyrimidines
#98 | 2014-08-14Substituted imidazopyridazines
#99 | 2014-07-316H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines
#100 | 2014-07-10Substituted aminoimidazopyridazines
91664 ⎘